Bird & Bird‘s Italian team is experienced in IP, transactional, regulatory, corporate, commercial, data protection, and EU and competition law; several team members can boast time working inside life sciences companies and regulatory bodies. The practice co-heads are IP litigators Giovanni Galimberti and Massimiliano Mostardini. Also integral to the practice are Antonella De Gregori, who has chemicals and pharmaceuticals expertise; Afra Casiraghi, who assists healthcare companies in Italy; Claudia Ricciardi, who advises both companies and research institutes; and experienced counsel Mauro Turrini. Evelina Marchesoni is a well-regarded senior associate.
Industry focus: Healthcare and life sciences in Italy
Bird & Bird
Practice head(s):
Other key lawyers:
Antonella De Gregori; Afra Casiraghi; Claudia Ricciardi; Mauro Turrini; Evelina Marchesoni
Testimonials
‘Practical advice and very responsive.‘
Key clients
Aboca Società Agricola
Adler Ortho
Axxam
Centro Cardiologico Monzino
Dompè Farmaceutici
Fondazione Telethon
Meda Pharma
Mylan
Ospedale San Raffaele
Rottapharm
San Donato Group
Sandoz
Teva
Actavis
Work highlights
- Assisted Sandoz with defending the award of two contracts for the supply of Dasatinib, a cancer growth blocker.
- Assisted Fondazione Telethon with the negotiation of a licensing agreement for industrial property rights.
- Advised Adler Ortho, a market leader in the research and production of orthopaedic prostheses, on a minority investment made by Space Capital Club.
BonelliErede
BonelliErede‘s healthcare and life sciences team has enviable knowledge of the pharmaceutical and biomedical markets; the practice fields experts in competition, environmental, administrative, tax and corporate law, along with litigation, M&A and IP. Of counsel and team leader Vincenzo Salvatore is a regulatory and compliance specialist in relation to clinical trials, marketing authorisation procedures, pharmacovigilance, personal data protection, inspections and enforcement, and medical devices’ promotion and marketing. At senior counsel level, Monica Fantino focuses on extraordinary transactions, and Francesco Mastroianni is a pharmaceutical sector-related regulatory and compliance expert.
Practice head(s):
Other key lawyers:
Monica Fantino; Francesco Mastroianni; Andrea Carta Mantiglia; Giovanni Guglielmetti; Giulio Ponzanelli
Key clients
Pikdare
Italian American Pharmaceutical Group
Kedrion
Zogenix International
Gilead
Pharma Mar
Medicines for Europe
Work highlights
- Prepared a legal opinion for Italian American Pharmaceutical Group on the role of AIFA in determining therapeutic equivalence between medicinal products with different active substances.
- Assisting Kedrion with access to documents concerning the auditing of blood centres, including pending legal proceedings before the Court of Justice of the EU.
- Assisted Pharma Mar in relation to administrative proceedings before the European Medicines Agency, as well as representation in the subsequent judicial phase against the European Commission before the Court of Justice of the European Union.
DLA Piper
Acting for both multinationals and Italian clients, DLA Piper‘s life sciences team routinely advises on multi-practice, multi-jurisdictional mandates. The full-service offering ranges from corporate, regulatory, IP, commercial and privacy matters to public procurement and PPP, litigation, white-collar crime, compliance, employment, real estate and finance. The team is led by Roberto Valenti, a partner in the Milan office’s IP and technology department and President of the the American Chamber of Commerce’s Life Sciences Working Group since 2010; Rome-based Marco de Morpurgo is a pharmaceutical and medical device regulatory law expert.
Practice head(s):
Other key lawyers:
Testimonials
‘Great preparation and knowledge of the subject, with a willingness to listen and compare.‘
‘A highly trained life sciences team.‘
‘The partners are extremely supportive, and always give feedback quickly and in a timely manner.‘
‘Strong proactivity and use of innovative tools to share regulatory news and updates that are useful for the sector, for example through webinars that focus on specific aspects.‘
‘Strong client orientation and attention to matching budget needs with quality of service to the maximum extent possible.‘
‘I have always worked very well with Roberto Valenti, an extremely professional person who is able to work well in a team, orchestrating the work of the group in an effective and client interest-oriented way.‘
‘I regularly work with Marco de Morpurgo on detailed aspects of Italian pharmaceutical law. He is my go-to guy in Italy.‘
‘In Italy, there are lots of good lawyers, but it can be challenging to find the top-notch cream of the crop. Marco de Morpurgo is definitely the cream of the crop.‘
Key clients
Pfizer
Abbott Medical
GlaxoSmithKline
Iovance Biotherapeutics
Vertex Pharmaceuticals
Essity
Sifi
Menarini
Medtronic
Reckitt Benkiser
Work highlights
- Advised the Italian entities of Pfizer on the organisation of the supply of Covid-19 vaccines distributed in Italy, in the Vatican City State and in the State of San Marino.
- Representing Medtronic in a patent dispute among European leading manufacturers and suppliers of a range of medical devices for respiratory support, in connection with the alleged infringement of two European patents referred to devices for oxygen administration in the intensive therapy.
- Assisted Sifi in its agreement with Chinese biopharmaceutical company AffaMed Therapeutics for a strategic joint venture in China aimed at developing, producing and marketing intraocular lenses and other surgical devices for the treatment of eye diseases in South East Asia.
Herbert Smith Freehills
Herbert Smith Freehills‘ Italy practice showcases several lawyers with scientific backgrounds. The group steers companies through discovery and research and development phases, and assists clients with the authorisation and launch of its products. Clients additionally benefit from the firm’s European platform, through which it co-ordinates dispute resolution, regulatory, corporate, commercial and competition matters. Managing partner of the Italy practice, Laura Orlando is an IP specialist with substantial life sciences sector expertise, and regularly assists household names with their biggest-selling products. IP litigator Sebastian Moore also has life sciences sector experience.
Practice head(s):
Other key lawyers:
Testimonials
‘The firm has a strong international footprint but maintains high levels of service and client orientation.‘
‘This is the firm that, in recent years, has managed to establish itself as a leader on the life sciences market, with capacity, competence and modesty.‘
‘Solid experience in the pharma and life science sector, and assists important clients with complex access, patents and regulatory issues.‘
‘No other firm knows the life sciences industry like Herbert Smith – undoubtedly the best in the business.‘
‘They have an innovative way of working – in fact it’s like having an internal outsourced legal team.‘
‘Laura Orlando was the first lawyer in Italy to truly specialise in the sector, working alongside the most important biotech companies as a kind of legal angel.‘
‘Laura Orlando is phenomenal and is forming a generation of resources, such as Sara Balice and Martina Maffei, who combine IP knowledge with regulatory knowledge like no one has been able to do on the Italian market so far.‘
‘Laura Orlando is an industry leader, who is very careful to balance client needs with appropriate budget control.‘
Key clients
Gilead Sciences
Millennium Pharmaceuticals
Federfarma.co
Eli Lilly
Mirnagreen
Zambon
Achilles Vaccines
Janssen
Lundbeck
Work highlights
- Acted for Millennium Pharmaceuticals (Takeda), Janssen and the US Government in a patent dispute commenced before the IP Court of Milan by Medac.
- Achieved a major victory for Germany’s biopharmaceutical company Novaliq in complex preliminary injunction proceedings brought before the Court of Rome.
- Advised Achilles Vaccines on all aspects of the research into the development of monoclonal antibodies for the treatment of Covid-19.
Hogan Lovells International LLP
Hogan Lovells International LLP‘s life sciences team is widely respected for its expertise in corporate and commercial matters, M&A, product liability and litigation, regulatory issues, IP and compliance. Clients additionally appreciate the group’s robust relationships with the Italian Health Authorities’ key officers. Heading up the Italian cross-practice life sciences team, Christian Di Mauro advises on product liability, compliance, regulation and safety, and Francesca Angeloni is a regulatory law specialist. Counsel Giuseppe Aminzade joined from Rucellai & Raffaelli in July 2021 to lead the firm’s Italy life sciences and healthcare regulatory department.
Practice head(s):
Other key lawyers:
Francesca Angeloni; Giuseppe Aminzade; Sabrina Borocci; Giovanni Ghirardi; Luigi Mansani; Francesca Rolla
Testimonials
‘This team provides high-quality, practical and client-friendly advice and constant availability.‘
‘Good balance between soft/hard skills and business understanding.‘
‘Great for the empathy and open-minded approach, in addition to the technical skills.‘
‘Francesca Rolla is very client friendly, practical and available. I like her balanced approach, which sets out clear choices when proceeding with cases.‘
Key clients
Angelini Holding
Baxter AG, Baxter
CHR Hansen Italia
Eli Lilly
Fidia Farmaceutici
Formula Pharmaceuticals
GE Healthcare
Grünenthal
Livanova
Orthofix
Qiagen Marseille
Recordati
Sorin Group – LivaNova
Sorin Group Italia
LivaNova Deutschland
Takeda Shire
Portolano Cavallo
Portolano Cavallo‘s practice routinely advises life sciences clients with the transactional, contractual, IP, contentious, compliance and regulatory aspects of the pharmaceuticals, medical devices and healthcare services sectors. It is also active in cosmetics, food supplements and pet food-related matters. The practice was recently involved in several projects regarding the digitalisation of healthcare services. Commercial contracts expert Luca Gambini founded the firm’s life sciences practice group, and Laura Liguori assists life sciences clients with digital and data protection matters. Regulatory and compliance specialist Elisa Stefanini was made partner in July 2021.
Practice head(s):
Other key lawyers:
Testimonials
‘Portolano’s healthcare and life sciences team is a very competent, agile, entrepreneurial firm that perfectly understands (and adapts itself to) clients’ needs.‘
‘Their billing practice is competitive and the team takes great care of clients.‘
‘Portolano is our go-to firm in Italy for life sciences questions.‘
‘They are in my view the most pragmatic life sciences law firm in Italy.‘
‘One of their strengths is to combine great technical competence with simple, clear and effective communication.‘
‘Luca Gambini and Elisa Stefanini are very trustworthy professionals to team up with. They are especially competent in healthcare regulations and digital health, as well as data protection, M&A and competition law.‘
‘Elisa Stefanini is extremely responsive.‘
‘Elisa Stefanini is appreciated for her high levels of competence.‘
Studio Professionale Associato a Baker & McKenzie
Studio Professionale Associato a Baker & McKenzie‘s team assists throughout the entire lifecycle of clients’ products, including manufacturing, research and development matters. Its expertise covers clinical trials, early access programmes for the sale of unlicensed medicines, obtaining licences and marketing. The practice also advises on pricing, distribution, post-marketing vigilance, product recalls, interactions with healthcare professionals and organisations, and public tenders and litigation. Roberto Cursano is a pharmaceutical and healthcare law expert, and Riccardo Ovidi, Mario Cigno, Miriam Allena and Francesca Baratta are key associates. Former partner Pierfrancesco Federici recently retired.
Practice head(s):
Other key lawyers:
Riccardo Ovidi; Mario Cigno; Miriam Allena; Francesca Baratta; Francesco Goisis
Testimonials
‘Thorough knowledge of the medtech sector and its regulations, and regularly updates with European life science newsletters.’
‘Great availability, flexible and understands clients’ needs.’
‘Roberto Cursano provides very practical advice, and is very knowledgeable in terms of tenders and pricing.’
‘Associate Mario Cigno is very knowledgeable in both the regulatory and public procurement side to medical devices.’
Key clients
AbbVie
Takeda Pharmaceutical
Abbott Laboratories
Stryker
MSD Italy
Paul Hartmann
ICU Medical
Zimmer Biomet Dental
Tillotts Pharma
Biogen
EUSA Pharma
ConvaTec
Crossmed
Regeneron
Bio-Rad Laboratories
Optikon 2000
Beaver-Visitec International Italy
Work highlights
- Assisted AbbVie with a legal integration process following its acquisition of Allergan.
- Assisted Takeda Pharmaceutical with an integration transaction in Italy following its acquisition of Shire.
- Assisted Abbott Laboratories with the global reorganisation and integration process following its acquisition of Alere.
Dentons
Dentons‘ life sciences and healthcare group combines public sector expertise with substantial experience in ordinary and extraordinary corporate transactions, including the acquisition of hospitals and nursing homes, and contract law matters involving healthcare operators. It also assists with cybersecurity, data protection and IP matters, along with administrative, civil and criminal disputes. The principal figures are transactions specialist Luca Pocobelli, Europe litigation leader Sara Biglieri and recently promoted partner Ilaria Gobbato.
Practice head(s):
Other key lawyers:
Sara Biglieri; Ilaria Gobbato; Andrea Pupeschi
Testimonials
‘High-level competence in the life sciences sector.‘
‘Availability, communication skills and speed.‘
‘Promptness in the analysis and the elaboration of the action to be taken.‘
‘Solid and focused determination in pursuing the client’s requests.‘
‘Willingness to adapt to the changing availability of the client.‘
‘Multidisciplinary team with an international network, and great availability from its professionals.‘
‘Great ease of communication and pleasant personal interactions from Ilaria Gobbato.‘
Key clients
Lifebrain
Johnson & Johnson
Ortho-Clinical Diagnostic Italy
NeoApotek
Mirova – Natixis Investment Managers
Affidea Group
Work highlights
- Assisting Lifebrain, which invests in the laboratory diagnostics sector across Europe, with several acquisitions, including the takeover of Nuovi Laboratori, which has several healthcare facilities and diagnostic laboratories.
- Assisting Ortho-Clinical Diagnostic Italy with several commercial, corporate, litigation, banking and regulatory matters.
- Assisted LifeScan, which specialises in diabetes management, on various regulatory and commercial matters surrounding the manufacturing, marketing, advertisement, sale and distribution of medical devices, as well as in vitro diagnostics.
LS CUBE Studio Legale
LS CUBE Studio Legale houses commercial, corporate and regulatory specialists who specialise in the life sciences industry, including healthcare, food and cosmetics. Paolo Ricci is noted for major deals; Paola La Licata, who acts for pharmaceutical and medical devices companies, has over 20 years’ experience in regulatory, compliance and commercial life sciences; and Rosanna Sovani is experienced in pharmaceutical industry-related regulatory, compliance and strategic corporate transactional matters, such as co-promotion and co-marketing agreements, global alliance and licence agreements, clinical trials, observational studies and services contracts. Massimiliano Marinozzi is an experienced litigator.
Practice head(s):
Paolo Ricci; Paola La Licata; Massimiliano Marinozzi; Rosanna Sovani
Testimonials
‘Despite the relatively small size of the firm, they have global reach. Their network is not physical (they do not have offices outside of Italy), yet any time I am in need of a piece of advice anywhere in the world, they seem to know the right professional and provide the right answer.‘
‘They offer innovative solutions and always deliver on what they promise; and when necessary, they know how to advocate on our behalf before the authorities.‘
‘Provides legal advice in all relevant fields of law: corporate, regulatory, contracts and compliance.‘
‘We are a small, newly established company in Italy, so it is of utmost importance for us to rely on a good network of practitioners; and LS CUBE is ideally shaped to establish a privileged relationship with its clients.‘
‘Great flexibility and speed of action.‘
‘The partners of the firm, together with their collaborators, have always managed the problems that emerge by proposing viable solutions.‘
‘Paolo Ricci and Massimiliano Marinozzi are my points of contact within the firm. They are available round the clock, and know how to take the problem off my shoulders and make me feel safe and relieved.‘
‘Paola La Licata is an outstanding professional, who always provides legal advice with a very pragmatic approach that is based on her good knowledge of sector specifics.‘
Key clients
Actial Farmaceutici
Agave
Arkopharma
Blue Bird bio
Bristol Myers Squibb
Celgene
Cheplapharm
Daiichi Sankyo
Diasorin
Exact Sciences
Federsalus
Gilead
Grant Thornton
HRA
IBSA Farmaceutici
Kedrion
Kyowa Kirin
Manni Oil
Novartis
Ospedale Bambin Gesù
OTI
PharmaExtracta
Pfizer
Roche
San Raffaele IRSS
Schwabe
Stallergenes
Vifor
Vifor Fresenius
Work highlights
- Co-ordinating an interest group named #VITA (Value and Innovation of Advanced Therapies) of which Gilead, bluebird bio, Novartis, Celgene and Sarepta are members.
- Assists, on an ongoing basis, Vifor, Daiichi, Vifor Fresenius and Kyowa Kirin with judicial claims brought against the Italian Agency of Pharmaceutical Products, aimed at challenging budget and payback resolutions issued by the agency for 2018 and 2019.
Orrick, Herrington & Sutcliffe
Orrick, Herrington & Sutcliffe‘s multidisciplinary life sciences group covers antitrust and competition, M&A, pharmaceutical regulatory, litigation, compliance and privacy matters, along with investigations, white-collar crime, technology, financings and corporate governance. The practice co-heads are Italian white-collar criminal defence team leader Jean-Paule Castagno and Pietro Merlino, the firm’s Italian antitrust and competition practice leader. Also key to the group is Attilio Mazzilli, who advises high-growth technology companies and venture capital firms. Marco Nicolini and Riccardo Troiano left the firm in late 2021.
Practice head(s):
Other key lawyers:
Testimonials
‘Very professional, competent and highly qualified team.‘
‘Very flexible, professional and highly competent professionals, with a great sense of priority and urgency and strong client sensitivity.‘
‘A team that is always ready and prepared and that assists our company in a timely and flexible manner on many issues and with a broad skillset.‘
Key clients
F Hoffmann-La Roche
Kedrion
Dompé Farmaceutici
Healthware Group
Bianalisi
Cerba HC Italia
Allelica
Lesaffre Italia
Gnosis
ACS Dobfar
M31/Adaptica
CoorsTek Medical
Work highlights
- Acting for pharmaceutical and biotech giant F Hoffman-La Roche in appeal proceedings arising from one of the most prominent antitrust cases brought in Italy over the last decade and concerning an alleged anti-competitive arrangement between the Roche and Novartis groups.
- Assisting Kedrion, a manufacturer and supplier of plasma-derived therapeutic products, with an ongoing investigation into alleged collusion launched by the Romanian Competition Authority against the company, its main global competitors and their pan-European trade association.
- Advising Bianalisi (an Italian medical laboratory company) on various transactions, including the purchase of ACTF Sanità Amica Srl and Sanità Amica Srl; the acquisition of the entire share capital of Brescia-based San Cristoforo; and the acquisition of Studio di Radiologia Ellisse.
Pavia e Ansaldo
Pavia e Ansaldo‘s go-to life sciences department covers IP litigation, regulatory, M&A, international healthcare, competition law and data protection. Head of the industrial and IP team Gian Paolo Di Santo is an experienced IP litigator for life sciences multinationals in Italy; competition law expert Filippo Fioretti is the former co-head of Simmons & Simmons’ Italian life sciences practice; and Marco Giustiniani represents the life sciences sector in administrative litigation involving public procurement bodies and the Italian Medicines Agency. Former partner Agostino Migone de Amicis joined LCA Studio Legale in January 2021.
Practice head(s):
Other key lawyers:
Testimonials
‘Great technical competence and a willingness to investigate all details.‘
Key clients
Actavis Italy
Accord
Intas
Laboratori Alter
Bonesupport
Ethypharm
ISDIN
Bio-Techne Corporation
Almirall e Almirall
Aristo Pharma Group
Work highlights
- Acting for Ethypharm in the first “clear the way action” involving a generic drug product in Italy (against originator Novartis).
- Acting for the pharmaceutical sector (as represented by a number of major life sciences companies) in major litigation against the Italian Health Agency over the so-called Hospital Budget.
- Assisting pharmaceutical giant Intas Pharmaceuticals with a request for access in the pharmaceutical sector to administrative documents.
ADVANT Nctm
ADVANT Nctm‘s life sciences practice acts for manufacturers, suppliers and regulators, as well as pharmaceutical, biotech and medical device companies. It also assists investors, private equity and venture capital funds, and public-private partnerships. Paolo Gallarati focuses on corporate and commercial law, compliance, and M&A and international business transactions; Lorena Possagno regularly advises major pharmaceutical clients; and Vito Bisceglie is a healthcare and health and social services sector expert.
Practice head(s):
Other key lawyers:
Testimonials
‘We particularly appreciated the communications from NCTM, which are always very clear (despite always being in English) and help us understand what our responsibilities are and the status of all outstanding items.‘
‘The NCTM team has perfect knowledge of M&A and commercial agreement practices in Italy. Their recommendations are very practical and it is very easy to work with them.‘
‘Great ability and effectiveness in all areas of legal advice, with expertise in all aspects related to the health/medical market.‘
‘Total availability and great focus on the client, with unparalleled effectiveness.‘
‘Ability to analyse complex problems and build reasonable solutions alongside the client.‘
‘NCTM was great, not only in providing legal advice and support, but also in helping us to find suppliers (for example for our bookkeeping and payroll activities).‘
‘Impeccable competence.‘
‘Lorena Possagno has strong experience in life sciences, and knows how to provide the best advice to clients. It is always a pleasure to work with her and her team.‘
Key clients
Aboca
Astrazeneca
Fresenius Group
Doc Generici
Gilead Sciences
Uriach Italy
Founders of Genetic
Hippocrates
Gyrus Capital
Opocrin
Allovir
Work highlights
- Assisting Aboca with the drafting, negotiation and reviewing of licence, distribution and supply agreements, in relation to non-implantable medical devices.
- Advising AstraZeneca on the compliance and data protection surrounding its core activities (pharmaceuticals) in Italy.
- Assisting Fresenius Group with its legal needs, including corporate, commercial and M&A matters, as well as compliance, privacy, administrative and data protection issues, particularly taking into consideration the applicable pharmaceutical regulations.
Chiomenti
The recent work of Chiomenti‘s pharmaceutical, healthcare and life sciences practice involved the review of authorisations and licences to sell medicinal products, clinical trials of products and vaccines, and several pharmaceutical market-related procedures. Heading up the firm’s pharma business unit, Luca Liistro advises on the particular requirements of the pharmaceutical and healthcare sectors; administrative law head Filippo Brunetti routinely acts for both pharmaceutical manufacturers and medical devices companies.
Practice head(s):
Other key lawyers:
Filippo Brunetti; Cristoforo Osti; Francesca Villa; Elio Leonetti; Alessandro Buscemi; Patrick Actis Perinetto
Testimonials
‘The firm’s strong point lies in being equipped with different professionals, even at an international level, who are specialised in various fields of law (including the pharmaceutical sector).‘
‘The professionals we interacted with are distinguished by their availability, speed and professionalism.‘
Key clients
Abbott
Air Liquide Sanità Service
Albis International
Alfasigma
Amplifon
Artsana
BioVelocITA
Carestream Dental Italy
Coloplast
Columbus Education Association
Fidia Farmaceutici
Forest Laboratories
Genoma Group
Gilead Sciences
Khiron
Laboratoires Expanscience
Lifebrain Group
LifeNet Health
Menarini Group
Merck Sharp & Dohme (Italia)
M I T Italia
Neuraxpharm
Recordati
Roche
SoBi Pharma
Surmodics
Techwald Holding
Zambon Group
Zobele
Work highlights
- Advised Fidia Farmaceutici on the acquisition of industrial assets, which were connected to a group of anti-inflammatory drugs.
- Advised Molecular Medicine on a Fininvest undertaking, which related to a voluntary tender offer launched by AGC for the shares of Molmed.
- Advising Investindustrial VI LP, Lifebrain Group and Laboratorio Analisi Guidonia on a complex operation in the pharmaceutical sector, which included corporate, administrative law, employment, tax and compliance matters.
Gianni & Origoni
With substantial expertise in the healthcare industry, Gianni & Origoni acts on a wide range of transactions, particularly in relation to chemistry and pharmaceutical-related matters. Corporate and commercial law, M&A and private equity specialist Rosario Zaccà heads the team, which includes environmental law group leader Antonella Capria; competition law expert Eva Cruellas Sada; and Antonio Lirosi, an administrative law specialist with a notable focus on tenders for works, supplies and services.
Practice head(s):
Other key lawyers:
Key clients
AbbVie
ArchiMed
Aspen
GE Medical System Italia
Herbalife Italia
Indena
Isagro
Leadiant Group
Livanova
medac
MSD
Novartis
Novartis Farma
Novo Nordisk
Orthofix
Patheon
Pharmaceutical Group FIS
Sanofi
Takeda Italia
Garofalo Health Care
Lonza
Rohm & Haas
Work highlights
- Assisted AbbVie with the largest venture capital-backed Series A funding round for an Italian biotechnology company to date.
- Assisting Novartis with one of the most important antitrust cases in Italy’s pharmaceutical sector in recent years.
- Assisted several companies of the Leadiant Group before the Italian Competition Authority with an abuse of dominance investigation, which raises a number of novel issues at the intersection of antitrust and pharmaceutical regulation.
Legance - Avvocati Associati
Legance – Avvocati Associati has developed notable expertise in life sciences and healthcare matters. It routinely assists Italian and foreign clients operating in all areas of this sector, including hospitals, and pharmaceutical and biotechnology entities. Senior partner Giovanni Nardulli advises healthcare operators on M&A transactions, including acquisitions of hospitals and other healthcare and life sciences companies, as well as investments and contracts involving the medical space and cosmetic use of cannabis.
Practice head(s):
Other key lawyers:
Filippo Pacciani; Monica Riva; Lorenzo Gentiloni Silveri; Ada Esposito
Testimonials
‘An available team with high-level skills in this sector.‘
‘Compared to other firms, I found a lot of professionalism and knowledge of this subject.‘
‘A lot of flexibility and availability in setting up meetings and strict compliance with deadlines.‘
‘Excellent, overall professionalism in various fields of law.‘
‘Timeliness, agile and shared and effective working methods, with a client management model that facilitates the overall coherence of the work.‘
‘The professionals have skills that are on average more transversal than their competitors.‘
‘Counsel Lorenzo Gentiloni is outstanding for competence, timeliness and dedication, as well as for flexibility in adapting the approach to the specific needs of the client by providing advice that is strategically valuable.‘
‘I work closely with counsel Lorenzo Gentiloni and am very satisfied with the work produced by him and his team.‘
Key clients
Agilent Technologies
Allergy Therapeutics
Amplifon
Charme Capital Partners SGR
C O T Cure Ortopediche Traumatologiche
CVC
DAI Optical
de Goetzen
DWS
Errant Gene Therapeutics
Eusphera
Farmavox
GB Pharma
Gemmo
Gruppo San Donato
Gruppo Villa Maria
Haemonetics
Hippocrates Holding
Hyris
Implant Protesis Dental 2004
Italsalute
IRCCS Istituto Ortopedico Galeazzi
IRCCS Ospedale San Raffaele
IRCCS Policlinico San Donato
Kolinpharma
KOS Group
MPilo
MSD Italia
Natural Point
Novartis Vaccines & Diagnostics
NPS Pharmaceuticals
Nutrilinea
RiverForce Partners
Sarepta Therapeutics
Teva Italia
U G A Nutraceuticals
Università Vita-Salute San Raffaele
Masotti Cassella
Masotti Cassella‘s team regularly advises Italian and international companies that are active in the life sciences sector, particularly medical devices, biotech and pharmaceutical businesses. Its expertise covers M&A, venture capital and private equity; the team also assists with public bids, procurement law, litigation, and agreements for licensing, distribution, R&D, original equipment manufacturers and clinical trials. Luca Masotti routinely advises significant manufacturers and distributors of medical and surgical devices.
Practice head(s):
Other key lawyers:
Testimonials
‘The experience was different from that with other law firms, both for the content and the professionalism of its people.‘
‘A lot of attention from the team during the initial stages and professionalism at all other times.‘
‘Luca Masotti’s competence is undoubted and his courtesy is at a high level.‘
Key clients
Ab Medica
Genomnia
Era Endoscopy
Officine Ortopediche Rizzoli
Biomat
Abex
abmedica
Ab Salud
Excelencia Robotica
Ab Renting
Rentalmed
Medical Labs
Fazzini
Eurapharma
Work highlights
- Assisting Officine Ortopediche Rizzoli with the study of a tender (managed by Aria) for the supply of orthopaedic devices for the Lombardy Region.
- Assisting abmedica with the sale of a technical assistance company branch to Accuray Europe.
- Assisting Telbios with litigation before the Administrative Courts in Milan, commenced by H&S for the revocation of a contract assigned to Telbios during a tender procedure for the offer of telemedicine services to patients.
Osborne Clarke
Osborne Clarke‘s Italy team routinely advises international life sciences companies on generic drugs, including Substitution List inclusion work and marketing authorisations. It also showcases experts in public law, as well as the burgeoning medtech area. With over 20 years’ experience in the sector, Maria Grazia Medici heads the life sciences team; and Federico Ferrara‘s transactional IP practice covers structured licensing, strategic partnering, drug supplies, and co-operative research and development.
Practice head(s):
Other key lawyers:
Federico Ferrara; Giulia Verusio; Sabrina Maiello; Carlos Suarez; Marialaura Boni
Testimonials
‘The firm guides the client in a competent, timely and proactive manner.‘
‘The creation of dedicated teams was the strength that allowed us to be successful in several legal cases faced.‘
‘The specialisation and skills and knowledge of our company have been winning aspects of our collaboration.‘
‘The firm offers an excellent package so that clients can benefit from a complete and multidisciplinary consultancy service.‘
‘A team that is continuously available and attentive to clients.‘
‘Great for the stability of the professional figures who led us to numerous successes.‘
‘Senior associate Sabrina Maiello is a winning weapon in the administrative law field.‘
Key clients
Grifols Italia
Teva Italia
Sciterion
SDM Società Dietetica Medica
Health Italia
Sicor Societa’ Italiana Corticosteroidi
Dentsply Sirona Italia
Dentsply Sirona Group
Actavis Italy
Work highlights
- Advising Grifols Italia on a wide range of pharmaceuticals matters, including a research collaboration agreement with the University of Pavia, participation in public tenders, and new product launches.
- Acting for SDM, an Italian healthcare company, on consultancy matters, R&D, and a range of commercial issues.
Pedersoli Studio Legale
Pedersoli Studio Legale‘s active healthcare and life sciences group comprises both contentious and non-contentious corporate and regulatory capabilities. In relation to the pharmaceutical, healthcare and medical industries, the team assists with complex white-collar matters, administrative law, public procurement, M&A, spinoffs and joint ventures. The key figures are administrative law head Sergio Fienga and healthcare and life sciences-related M&A expert Luca Saraceni.
Practice head(s):
Other key lawyers:
Testimonials
‘The team is very prepared, and has the ability to listen and explore scientific/legal issues that are not easy to understand.‘
‘Excellent professionalism, seriousness and intuitive skills.‘
‘The ability and willingness to understand and evaluate not only the legal aspects, but also the technical ones creates a winning synergy, where the professional, on the basis of legal knowledge, is able to expose the complexity in the best and most effective way.‘
‘Knowledge, availability and curiosity – an extremely well-trained, competent and helpful team.‘
‘Always listening, with the ability to deepen down to the smallest detail the arguments of the cases.‘
‘One always has the impression of speaking with professionals who have everything under control.‘
‘Competence and flexibility, with the availability of different consultants depending on the area.‘
‘Senior associate Alessandro Zuccaro always adds value by finding solutions or facilitating critical issues. His ability to simplify the bureaucratic rules has contributed to our success in several judgments.‘
Key clients
Opis
Gyrus Capital
DiaSorin
Boston Scientific Italia
Elekta
Philips
Esaote
Advanced Sterilization Products Italia
Hollycon Italy
Italmobiliare
Work highlights
- Assisting DiaSorin, globally known for in vitro diagnostics, with a merger agreement for the acquisition of Luminex, a US-based company that develops, manufactures and sells proprietary technologies and products for biological tests.
- Assisting Gyrus Capital, an investment firm dedicated to private equity investments in the healthcare and sustainability sectors, with an agreement with PwC Italia whereby entities owned and controlled by Gyrus-advised funds will acquire PwC Italia’s consulting business, which provides advisory services to the Italian public administration and public healthcare system.
Trevisan & Cuonzo
Life sciences work is core to Trevisan & Cuonzo‘s IP practice, which is experienced in pharmaceutical, biotech and medical device litigation, as well as life sciences regulatory work. The practice co-heads are IP and life sciences specialist Gabriel Cuonzo; Daniela Ampollini, who advises Italian and international pharmaceutical companies on biotech products; and pharmaceutical company expert Donatella Capelli. At associate level, Luca Pellicciari regularly assists with significant pharmaceutical and biotech cases.
Practice head(s):
Other key lawyers:
Testimonials
‘The firm is well known in the Italian market and has been trustworthy for many years.‘
‘I have worked with them on several cases. I particularly enjoyed working with them on a co-ordination case where they provided quality work.‘
‘T&C has an excellent team for handling complex litigation in international settings.‘
‘Among the best IP attorneys in Italy.‘
‘Gabriel Cuonzo is very well known and Donatella Capelli provides very good work, coming up with her own understanding of the case so as to adapt the arguments to Italian judges.‘
‘Gabriel Cuonzo is very experienced and has a strategic mind.‘
‘Donatella Capelli is very engaged – an excellent fighter in court.‘
Work highlights
- Represented Boehringer Ingelheim before the Court of Appeal of Milan in relation to patent rights covering the active ingredient of a blockbuster product for respiratory diseases.
- Successfully represented Industria Chimica Emiliana (and its subsidiary Prodotti Chimici e Alimentari) before the Italian Antitrust Authority.
- Acted for Heraeus Medical and Heraeus in proceedings concerning violations of valuable trade secrets.